More Nomograms or Better Evidence of Efficacy: What Do We Need in Urologic Oncology?

European Urology

Volumn 54, Issue 1, 2008, Pages 11-12

  Catto, James W F ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER STAGING; CLINICAL DECISION MAKING; CYSTECTOMY; CYSTOSCOPY; ECONOMICS; EDITORIAL; HUMAN; KIDNEY CANCER; NOMOGRAM; ONCOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; UROLOGIC ONCOLOGY;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 44149093137     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.01.064     Document Type: Editorial

References (10)

1. Kattan M.W., Eastham J.A., Stapleton A.M., Wheeler T.M., and Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
2. Shariat S.F., Margulis V., Lotan Y., Montorsi F., and Karakiewicz P.I. Nomograms for bladder cancer. Eur Urol 54 (2008) 41-53
3. Available from: www.nomogram.org. Accessed 17 January 2008.
4. Karakiewicz P.I., Briganti A., Chun F.K., et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 25 (2007) 1316-1322
5. Catto J.W., Linkens D.A., Abbod M.F., et al. Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks. Clin Cancer Res 9 (2003) 4172-4177
6. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
7. Chant C., Wilson G., and Friedrich J.O. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy 25 (2005) 352-359
8. Zippe C., Pandrangi L., and Agarwal A. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer. J Urol 161 (1999) 62-65
9. Guillonneau B. Ceteris paribus and nomograms in medicine. Eur Urol 52 (2007) 1287-1289
10. Carroll P.R. Early stage prostate cancer-do we have a problem with over-detection, overtreatment or both?. J Urol 173 (2005) 1061-1062